India's Permanent Mission to the United Nations, Geneva, revealed that the country has contributed $ 400,000 (over Rs 3 crore) to as many as four Voluntary Trust Funds.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS